Susko Matthew, Yu Yao, Ma Lijun, Nakamura Jean, Fogh Shannon, Raleigh David R, Golden Encouse, Theodosopoulos Philip V, McDermott Michael W, Sneed Penny K, Braunstein Steve E
Department of Radiation Oncology, San Francisco, California.
Department of Neurological Surgery, San Francisco, California.
Adv Radiat Oncol. 2019 Mar 14;4(3):458-465. doi: 10.1016/j.adro.2019.03.002. eCollection 2019 Jul-Sep.
The incidence of brain metastases is increasing as a result of more routine diagnostic imaging and improved extracranial systemic treatment strategies. As noted in recent consensus guidelines, postoperative stereotactic radiosurgery (SRS) to the resection cavity has lower rates of local control than whole brain radiation therapy but improved cognitive outcomes. Further analyses are needed to improve local control and minimize toxicity.
Patients receiving SRS to a resection cavity between 2006 and 2016 were retrospectively analyzed. Presurgical variables, including tumor location, diameter, dural/meningeal contact, and histology, were collected, as were SRS treatment parameters. Patients had routine follow-up with magnetic resonance imaging, and those noted to have local failure were further assessed for the recurrence location, distance from the target volume, and dosimetric characteristics.
Overall, 82 patients and 85 resection cavities underwent postoperative SRS during the study period. Of these, 58 patients with 60 resection cavities with available follow-up magnetic resonance imaging scans were included in this analysis. With a median follow-up of 19.8 months, local recurrence occurred in 12 of the resection cavities for a 15% 1-year and 18% 2-year local recurrence rate. Pretreatment tumor volume contacted the dura/meninges in 100% of cavities with recurrence versus 67% of controlled cavities ( = .025). A total of 5 infield, 5 marginal, and 4 out-of-field recurrences were found, with a median distance to the centroid from the target volume of 3 mm. The addition of a 10-mm dural margin increased the target volume overlap with the recurrence contours for 10 of the 14 recurrences.
Dural contact was associated with an increased rate of recurrence for patients who received SRS to a surgical cavity, and the median distance of marginal recurrences from the target volume was 3 mm. These results provide evidence in support of recent consensus guidelines suggesting that additional dural margin on SRS volumes may benefit local control.
由于更常规的诊断成像和颅外全身治疗策略的改进,脑转移瘤的发病率正在上升。正如最近的共识指南中所指出的,对切除腔进行术后立体定向放射外科治疗(SRS)的局部控制率低于全脑放射治疗,但认知结果有所改善。需要进一步分析以改善局部控制并使毒性最小化。
对2006年至2016年间接受切除腔SRS治疗的患者进行回顾性分析。收集术前变量,包括肿瘤位置、直径、硬脑膜/脑膜接触情况和组织学,以及SRS治疗参数。患者接受磁共振成像常规随访,对那些被发现有局部失败的患者进一步评估复发位置、距靶体积的距离和剂量学特征。
总体而言,在研究期间82例患者和85个切除腔接受了术后SRS治疗。其中,本分析纳入了58例患者的60个切除腔,其有可用的随访磁共振成像扫描。中位随访时间为19.8个月,12个切除腔发生局部复发,1年局部复发率为15%,2年局部复发率为18%。复发的切除腔中100%的术前肿瘤体积与硬脑膜/脑膜接触,而对照切除腔中这一比例为67%(P = 0.025)。共发现5例野内、5例边缘和4例野外复发,距靶体积质心的中位距离为3 mm。对于14例复发中的10例,增加10 mm的硬脑膜边缘增加了靶体积与复发轮廓的重叠。
硬脑膜接触与接受切除腔SRS治疗患者的复发率增加相关,边缘复发距靶体积的中位距离为3 mm。这些结果为支持最近的共识指南提供了证据,该指南表明在SRS体积上增加硬脑膜边缘可能有利于局部控制。